Loading organizations...
§ Private Profile · Neue Grunstrasse 17, Berlin, Germany
Digital health and AI healthcare platform developing AI-powered symptom assessment and care navigation for consumers and healthcare organizations.
Ada Health has raised $167.0M across 3 funding rounds.
Key people at Ada Health.
Ada Health was founded in 2011 by Claire Novorol (Co-founder and Chief Medical Officer).
Ada Health has raised $167.0M in total across 3 funding rounds.
Founded in 2011 and based in Berlin, Germany, Ada Health develops an AI-powered symptom assessment and care navigation platform that helps individuals understand their medical conditions. The company operates a B2B SaaS model alongside its consumer application, licensing its triage technology to major health systems, insurers, and pharmaceutical companies like Novartis, Sutter Health, and Jefferson Health. Serving as a top-ranked medical application in over 130 countries, the platform supports more than 13 million global users who have completed over 30 million symptom assessments. Ada Health has raised approximately $190 million in total funding, highlighted by a $120 million Series B round backed by investors Leaps by Bayer and Samsung Catalyst Fund. The digital health startup was established by founders Daniel Nathrath, Claire Novorol, and Martin Hirsch to shift healthcare toward a proactive, patient-first model.
Key people at Ada Health.
Ada Health has raised $167.0M across 3 funding rounds. Most recently, it raised $30.0M Series B Extension in February 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 10, 2022 | $30M Series B Plus | — | Joern Caumanns, Farallon Capital Management, Antoine Boulin | Announced |
| May 27, 2021 | $90M Series B | Juergen Eckhardt | F4, Inteligo Bank, Mutschler Ventures, Samsung Catalyst Fund, Vitruvian Partners | Announced |
| Oct 1, 2017 | $47M Series A | Guillaume D'hauteville | Hambro Perks, Sherry Coutu, William Tunstall Pedoe, Cumberland VC, Philipp Schindler | Announced |
Ada Health was founded in 2011 by Claire Novorol (Co-founder and Chief Medical Officer).
Ada Health has raised $167.0M in total across 3 funding rounds.
Ada Health's investors include Joern Caumanns, Farallon Capital Management, Antoine Boulin, Juergen Eckhardt, F4, Inteligo Bank, Mutschler Ventures, Samsung Catalyst Fund, Vitruvian Partners, Guillaume d'Hauteville, Hambro Perks, Sherry Coutu.
Ada Health is a Berlin-based global health technology company that develops an AI-powered symptom assessment app and enterprise solutions to guide users toward better health outcomes. Founded by doctors, it serves 13 million consumers via its app—completing 32 million assessments, with a new check every three seconds—while partnering with healthcare systems, insurers, payers, life sciences firms, employers, governments, and non-profits to enable triage, informed decisions, and cost reduction.[1][2][3]
The core product, Ada Assess (a Class IIa medical device in Europe), uses clinically validated AI to analyze symptoms, medical history, and demographics, outperforming many peers in accuracy with 25+ peer-reviewed studies. With $317M raised as of October 2025 (latest round: $30M in February 2022) and $63M in revenue, Ada demonstrates strong growth in digital health, addressing access gaps amid rising demand for scalable care navigation.[1][3][4]
Ada Health was founded in 2011 in Berlin by Dr. Claire Novorol (clinician and Chief Medical Officer), Professor Martin Hirsch (AI expert), and Daniel Nathrath (entrepreneur).[4][5] The idea stemmed from Novorol's experience at Addenbrooke's Hospital in Cambridge, UK, where she diagnosed a rare genetic condition in a baby using medical literature searches, highlighting AI's potential for faster, accurate clinical decisions.[4]
Initially launched as "Ada DX," a clinical decision support tool for doctors diagnosing rare diseases, the company pivoted in 2016 to a consumer-facing symptom checker app (Ada Assess) after Novorol built the "Doctorpreneurs" network in Berlin.[4][6] Early traction came from browser and mobile tools empowering patients directly, evolving into enterprise solutions amid growing AI health adoption; pivotal moments include 2020 Broadband Commission recognition for reducing inequalities and partnerships like Santéclair in France.[3][4]
Ada rides the AI-driven digital health wave, capitalizing on post-pandemic demand for accessible, scalable care amid clinician shortages and rising costs. Its timing aligns with regulatory progress (e.g., EU Class IIa approval) and trends like telemedicine growth, enabling "digital front doors" for health systems.[4][6][7]
Market forces favor Ada: exploding AI health adoption (named in Top 25 Digital Health Companies of 2025), payer incentives for triage to cut avoidable visits, and global inequalities in access that symptom checkers address every three seconds.[1][2][7] It influences the ecosystem by partnering across 60+ French insurers via Santéclair, supporting NHS indirectly, and providing evidence-based tools that optimize workflows and equity.[3][4]
Ada's momentum—fueled by $317M funding, 13M users, and enterprise expansion—positions it for deeper integration into health ecosystems, potentially via U.S. growth (Boca Raton office) and new AI features for predictive care.[1][4] Trends like multimodal AI, personalized medicine, and regulatory harmonization (e.g., FDA alignments) will shape its path, amplifying impact on outcomes and costs.
As AI transforms knowledge into action, Ada exemplifies how doctor-led tech scales human expertise globally, evolving from hospital origins to a validated leader in clinical intelligence.
